Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Eric A. Adams currently holds 14,300 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric A. Adams has been a net buyer of INM stock. They have purchased $70.0K and sold $0 worth of shares.
Eric A. Adams's most recent insider trade was on Dec 20, 2024, when they sold 6,250 shares at $0.00 per share.
Eric A. Adams serves as Executive at InMed Pharmaceuticals Inc. (INM). They have executed 7 insider transactions totaling $70.0K over their tenure at the company.
Eric A. Adams holds the position of Executive at InMed Pharmaceuticals Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Eric A. Adams has shown a buying trading pattern, with $70.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Eric A. Adams was on Sep 28, 2021, when they purchased $19.9K worth of INM shares. This transaction involved 11,400 shares at $1.75 per share.
Eric A. Adams currently owns 14,300 shares of InMed Pharmaceuticals Inc. (INM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Eric A. Adams's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Eric A. Adams has 7 Form 4 filings on record as an insider at InMed Pharmaceuticals Inc..
Set alerts for Eric A. Adams and 40,000+ other insiders.